Viral Shah, MD, pointed to missed insulin doses as one of the main contributors to therapeutic inertia for these patients. Data from multiple studies indicate up to 30% of people with type 2 diabetes miss at least one basal insulin dose per month. Continuous glucose monitoring, connected insulin pens, and automated insulin delivery may be key to overcoming this challenge.
Get email updates from ADAMeetingNews.org
Subscribe to get regular news updates about the Scientific Sessions.
You can also subscribe to receive other email communications from the American Diabetes Association.